M Beran
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 8
- Chronic Myeloid Leukemia Treatments 5
- Genetics 6
- Chronic Lymphocytic Leukemia Research 6
- Co-authors
- Ming-Sheng LeeJ C WangSima JehaMoshe TalpazHagop M. KantarjianSusan O’BrienRazelle KurzrockNicholas Lydon
- Journals
- Blood (6 papers)Cancer (2 papers)Journal of Clinical Oncology (2 papers)Journal of Molecular Biology (1 paper)PubMed (7 papers)
- Partner nations
- United StatesSwedenUnited Kingdom
In The Last Decade
M Beran
18 papers receiving 782 citations
Peers
Comparison fields: 5 of 57
- Hematology 407
- Genetics 302
- Oncology 209
- Rheumatology 113
- Immunology 121
Countries citing papers authored by M Beran
This map shows the geographic impact of M Beran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Beran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Beran more than expected).
Fields of papers citing papers by M Beran
This network shows the impact of papers produced by M Beran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Beran. The network helps show where M Beran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M Beran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 7 | |
| 2 | Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells. | 2001 | 14 |
| 3 | Intensive chemotherapy for patients with high-risk myelodysplastic syndrome. | 2000 | 41 |
| 4 | Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia. | 1999 | 67 |
| 5 | Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148). | 1998 | 148 |
| 6 | Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice. | 1996 | 6 |
| 7 | Antisense RNA inhibition of phosphoprotein p18 expression abrogates the transformed phenotype of leukemic cells. | 1996 | 60 |
| 8 | 1995 | 18 | |
| 9 | 1994 | 60 | |
| 10 | 1994 | 3 | |
| 11 | Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase. | 1993 | 53 |
| 12 | 1992 | 85 | |
| 13 | 1992 | 5 | |
| 14 | 1992 | 101 | |
| 15 | 1988 | 39 | |
| 16 | 1988 | 36 | |
| 17 | 1985 | 33 | |
| 18 | 1983 | 36 |
About M Beran
M Beran is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Immunology and Pathology and Forensic Medicine, having authored 18 papers that have together received 812 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Retinoids in leukemia and cellular processes (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Hematology (407 citations), Genetics (302 citations), Oncology (209 citations), Rheumatology (113 citations) and Immunology (121 citations). M Beran has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Ming-Sheng Lee, J C Wang, Sima Jeha, Moshe Talpaz, Hagop M. Kantarjian, Susan O’Brien, Razelle Kurzrock, Nicholas Lydon, Xuanye Cao and R B Arlinghaus. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, Journal of Molecular Biology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.